Valuation: Aprogen Medicines Inc.

Market Cap 50.64B 36.54M 31.3M 29.29M 26.81M 50.31M 3.5B 50.98M 346M 135M 1.76B 137M 134M 5.81B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 188B 135M 116M 109M 99.39M 187M 12.96B 189M 1.28B 500M 6.51B 509M 498M 21.54B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
79.55%
Yield 2024 *
-
Yield 2025 -
1 day-2.77%
1 week-11.28%
Current month-1.30%
1 month+6.05%
3 months-45.84%
6 months-66.07%
Current year-78.19%
1 week 2,230
Extreme 2230
2,610
1 month 1,961
Extreme 1961
2,745
Current year 1,961
Extreme 1961
11,880
1 year 1,961
Extreme 1961
14,070
3 years 1,961
Extreme 1961
38,250
5 years 1,961
Extreme 1961
110,250
10 years 1,961
Extreme 1961
875,250
Manager TitleAgeSince
Chief Executive Officer 63 2017-12-26
Comptroller/Controller/Auditor 69 2018-03-27
Director TitleAgeSince
Director/Board Member 63 2022-11-28
Director/Board Member 64 2022-07-17
Director/Board Member 62 2023-10-12
Date Insider Type Main position Quantity % Market Cap.
1/17/25 Others 7,673 0.0025%
1/19/24 Free 101,429 0.0383%
1/19/24 Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-2.77%-11.28%-77.75%-93.49% 36.54M
+1.78%-1.76%+14.91%+52.01% 15.36B
-0.72%-8.18%+170.21%+303.46% 13.92B
+3.59%-4.02%-30.51%+18.50% 5.06B
+0.73%+8.57%+129.87%+121.29% 3.23B
+3.53%-0.05%+25.96%+39.17% 3.06B
-1.98%+3.62%+110.79%+224.90% 1.72B
+1.80%-2.51%-14.43%-14.91% 1.01B
+0.91%-0.35%+14.44%+7.89% 999M
-1.51%+10.95%+19.90%+71.28% 786M
Average +0.54%-3.03%+36.34%+73.01% 4.52B
Weighted average by Cap. +1.03%-4.17%+69.65%+134.15%

Financials

2024 2025
Net sales 150B 108M 92.78M 86.81M 79.47M 149M 10.36B 151M 1.03B 400M 5.21B 407M 398M 17.22B 118B 85.13M 72.92M 68.23M 62.45M 117M 8.14B 119M 806M 314M 4.09B 320M 313M 13.53B
Net income -58.08B -41.91M -35.9M -33.59M -30.75M -57.7M -4.01B -58.47M -397M -155M -2.01B -157M -154M -6.66B -70.2B -50.66M -43.39M -40.6M -37.16M -69.75M -4.85B -70.67M -480M -187M -2.43B -190M -186M -8.05B
Net Debt 70.04B 50.54M 43.29M 40.51M 37.08M 69.59M 4.84B 70.51M 479M 187M 2.43B 190M 186M 8.03B 137B 98.93M 84.74M 79.29M 72.58M 136M 9.47B 138M 937M 365M 4.75B 371M 363M 15.73B
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
253
Date Price Change Volume
26-08-21 ₩2,280.00 -2.77% 92,133
26-08-20 ₩2,345.00 -1.47% 92,003
26-08-19 ₩2,380.00 -3.64% 85,049
26-08-18 ₩2,470.00 -3.89% 89,707
26-08-14 ₩2,570.00 -1.15% 106,239
  1. Stock Market
  2. Stocks
  3. A007460 Stock